Interleukin-2 in Treating Children Who Have Undergone Bone Marrow Transplantation for Acute Myeloid Leukemia
Study Details
Study Description
Brief Summary
RATIONALE: Interleukin-2 may stimulate a person's white blood cells to kill more cancer cells.
PURPOSE: Phase I trial to study the effectiveness of interleukin-2 in treating children who have undergone bone marrow transplantation for acute myeloid leukemia.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Phase 1 |
Detailed Description
OBJECTIVES: I. Determine the maximum tolerated dose of interleukin-2 after autologous bone marrow transplantation in pediatric patients with acute myeloid leukemia. II. Determine toxic effects of this regimen in these patients.
OUTLINE: This is a dose escalation study. Patients receive interleukin-2 (IL-2) subcutaneously on days 1-7, 9-14, and 16-22. On days 8 and 15, patients receive IL-2 IV over 2 hours. Treatment repeats every 28 days for up to 4 courses in the absence of disease progression or unacceptable toxicity. Cohorts of 6-9 patients receive escalating doses of IL-2 until the maximum tolerated dose (MTD) is determined. The MTD is defined as the dose preceding that at which 2 of 6 or 2 of 9 patients experience dose-limiting toxicity. Patients are followed every 6 months for 4 years and then annually thereafter.
PROJECTED ACCRUAL: A total of 6-27 patients will be accrued for this study.
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: All patients Day 1 through day 7, days 9-14 and days 16-22: The assigned dose of IL-2 will be administered SQ. On days 8 and 15, IL-2 will be administered as a 2 hour intravenous infusion of one million units/M2 of IL-2. After day 22 there will be a 7 day rest period before beginning the next cycle. The next cycle will repeat just as above. This will be repeated for a maximum of 4 total cycles of 21 days of IL-2 therapy. The maintenance dose of IL-2 will always be the same as given during cycle one, unless there is dose limiting toxicity. |
Biological: aldesleukin
Given SQ and IV
Other Names:
|
Outcome Measures
Primary Outcome Measures
- To determine the maximum tolerated dose (MTD) of IL-2 [2 years]
Eligibility Criteria
Criteria
DISEASE CHARACTERISTICS: Diagnosis of acute myeloid leukemia (AML) Must have received autologous bone marrow or stem cell transplantation for AML within the past 28 to 100 days Evidence of marrow engraftment Absolute neutrophil count at least 500/mm3 for at least 2 consecutive days Platelet count at least 20,000/mm3 without transfusion support for more than 3 days Documented M1 or M2 bone marrow within the past 7 days
PATIENT CHARACTERISTICS: Age: Under 22 at diagnosis Performance status: Karnofsky 50-100%
Life expectancy: At least 8 weeks Hematopoietic: See Disease Characteristics Hepatic:
Bilirubin no greater than 1.5 mg/dL SGPT no greater than 2 times normal Renal: Creatinine normal OR Glomerular filtration rate at least 70 mL/min Cardiovascular: Shortening fraction at least 27% OR Ejection fraction greater than 50% No evidence of active cardiac disease by electrocardiogram Pulmonary: No evidence of active pulmonary disease by chest x-ray Other: Not pregnant or nursing Negative pregnancy test Fertile patients must use effective contraception Neurologic deficits due to CNS disease must be stable within the past 4 weeks No active viral, bacterial, or invasive fungal infection No fever No prior hypersensitivity to interleukin-2 No greater than grade 2 mucosal toxicity
PRIOR CONCURRENT THERAPY: Biologic therapy: See Disease Characteristics At least 3 days since prior growth factors or intravenous immunoglobulin No concurrent cytokines or growth factors No concurrent intravenous immunoglobulin Chemotherapy: No concurrent chemotherapy No concurrent methotrexate IV or intrathecally Endocrine therapy: At least 3 days since prior corticosteroids No concurrent corticosteroids (except as premedication for documented severe transfusion reactions) Radiotherapy: Not specified Surgery: Not specified Other: At least 3 days since prior pentoxifylline or amphotericin B No concurrent pentoxifylline No other concurrent anticancer therapy
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | University of Alabama at Birmingham Comprehensive Cancer Center | Birmingham | Alabama | United States | 35294-3300 |
2 | University of South Alabama Medical Center | Mobile | Alabama | United States | 36617-2293 |
3 | MBCCOP - Gulf Coast | Mobile | Alabama | United States | 36688 |
4 | Arizona Cancer Center | Tucson | Arizona | United States | 85724 |
5 | Arkansas Children's Hospital | Little Rock | Arkansas | United States | 72202-3591 |
6 | University of Arkansas for Medical Sciences | Little Rock | Arkansas | United States | 72205 |
7 | University of California San Diego Cancer Center | La Jolla | California | United States | 92093-0658 |
8 | Lucile Packard Children's Hospital at Stanford | Palo Alto | California | United States | 94304 |
9 | Sutter Cancer Center | Sacramento | California | United States | 95816 |
10 | University of California Davis Medical Center | Sacramento | California | United States | 95817 |
11 | Kaiser Permanente-Southern California Permanente Medical Group | San Diego | California | United States | 92120 |
12 | Children's Hospital and Health Center | San Diego | California | United States | 92123-4282 |
13 | Kaiser Permanente Medical Center - Santa Clara | Santa Clara | California | United States | 95051-5386 |
14 | Yale Comprehensive Cancer Center | New Haven | Connecticut | United States | 06520-8028 |
15 | Walter Reed Army Medical Center | Washington | District of Columbia | United States | 20307-5000 |
16 | Broward General Medical Center | Fort Lauderdale | Florida | United States | 33316 |
17 | Children's Hospital of Southwest Florida | Fort Myers | Florida | United States | 33908 |
18 | Shands Hospital and Clinics, University of Florida | Gainesville | Florida | United States | 32610-100277 |
19 | Nemours Children's Clinic | Jacksonville | Florida | United States | 32207 |
20 | Sylvester Cancer Center, University of Miami | Miami | Florida | United States | 33136 |
21 | University of Miami-Jackson Memorial Hospital Medical Center | Miami | Florida | United States | 33136 |
22 | Miami Children's Hospital | Miami | Florida | United States | 33155 |
23 | Baptist Hospital of Miami | Miami | Florida | United States | 33176-2197 |
24 | Walt Disney Memorial Cancer Institute | Orlando | Florida | United States | 32803 |
25 | All Children's Hospital | St. Petersburg | Florida | United States | 33701 |
26 | CCOP - Florida Pediatric | Tampa | Florida | United States | 33682-7757 |
27 | St. Mary's Hospital | West Palm Beach | Florida | United States | 33407 |
28 | Emory University Hospital - Atlanta | Atlanta | Georgia | United States | 30322 |
29 | Cancer Research Center of Hawaii | Honolulu | Hawaii | United States | 96813 |
30 | Tripler Army Medical Center | Honolulu | Hawaii | United States | 96859-5000 |
31 | Rush-Presbyterian-St. Luke's Medical Center | Chicago | Illinois | United States | 60612 |
32 | Children's Memorial Hospital, Chicago | Chicago | Illinois | United States | 60614 |
33 | Hope Children's Hospital | Oak Lawn | Illinois | United States | 60453 |
34 | CCOP - Illinois Oncology Research Association | Peoria | Illinois | United States | 61602 |
35 | Saint Jude Midwest Affiliate | Peoria | Illinois | United States | 61637 |
36 | University of Kansas Medical Center | Kansas City | Kansas | United States | 66160-7357 |
37 | CCOP - Wichita | Wichita | Kansas | United States | 67214-3882 |
38 | Via Christi Regional Medical Center | Wichita | Kansas | United States | 67214 |
39 | MBCCOP - LSU Health Sciences Center | New Orleans | Louisiana | United States | 70112 |
40 | Tulane University School of Medicine | New Orleans | Louisiana | United States | 70112 |
41 | CCOP - Ochsner | New Orleans | Louisiana | United States | 70121 |
42 | Eastern Maine Medical Center | Bangor | Maine | United States | 04401 |
43 | Maine Children's Cancer Program | Portland | Maine | United States | 04101 |
44 | Marlene & Stewart Greenebaum Cancer Center, University of Maryland | Baltimore | Maryland | United States | 21201 |
45 | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Baltimore | Maryland | United States | 21231-2410 |
46 | Boston Floating Hospital Infants and Children | Boston | Massachusetts | United States | 02111 |
47 | Massachusetts General Hospital Cancer Center | Boston | Massachusetts | United States | 02114 |
48 | Dana-Farber Cancer Institute | Boston | Massachusetts | United States | 02115 |
49 | University of Massachusetts Memorial Medical Center | Worcester | Massachusetts | United States | 01655 |
50 | Children's Hospital of Michigan | Detroit | Michigan | United States | 48201 |
51 | St. John's Hospital and Medical Center | Detroit | Michigan | United States | 48236 |
52 | Hurley Medical Center | Flint | Michigan | United States | 48503 |
53 | University of Mississippi Medical Center | Jackson | Mississippi | United States | 39216-4505 |
54 | Keesler Medical Center - Keesler AFB | Keesler AFB | Mississippi | United States | 39534-2576 |
55 | University of Missouri-Columbia Hospital and Clinics | Columbia | Missouri | United States | 65212 |
56 | Cardinal Glennon Children's Hospital | Saint Louis | Missouri | United States | 63104 |
57 | Washington University School of Medicine | Saint Louis | Missouri | United States | 63110 |
58 | Norris Cotton Cancer Center | Lebanon | New Hampshire | United States | 03756-0002 |
59 | CCOP - Northern New Jersey | Hackensack | New Jersey | United States | 07601 |
60 | Hackensack University Medical Center | Hackensack | New Jersey | United States | 07601 |
61 | University of New Mexico School of Medicine | Albuquerque | New Mexico | United States | 87131 |
62 | Roswell Park Cancer Institute | Buffalo | New York | United States | 14263-0001 |
63 | Schneider Children's Hospital | New Hyde Park | New York | United States | 11042 |
64 | Mount Sinai School of Medicine | New York | New York | United States | 10029 |
65 | University of Rochester Cancer Center | Rochester | New York | United States | 14642 |
66 | State University of New York Health Sciences Center - Stony Brook | Stony Brook | New York | United States | 11790-7775 |
67 | State University of New York - Upstate Medical University | Syracuse | New York | United States | 13210 |
68 | Mission Saint Joseph's Health System | Asheville | North Carolina | United States | 28801 |
69 | Carolinas Medical Center | Charlotte | North Carolina | United States | 28232-2861 |
70 | Presbyterian Healthcare | Charlotte | North Carolina | United States | 28233-3549 |
71 | Duke Comprehensive Cancer Center | Durham | North Carolina | United States | 27710 |
72 | East Carolina University School of Medicine | Greenville | North Carolina | United States | 27858-4354 |
73 | Comprehensive Cancer Center at Wake Forest University | Winston-Salem | North Carolina | United States | 27157-1082 |
74 | Oklahoma Memorial Hospital | Oklahoma City | Oklahoma | United States | 73126-0307 |
75 | Natalie Warren Bryant Cancer Center | Tulsa | Oklahoma | United States | 74136 |
76 | CCOP - Columbia River Program | Portland | Oregon | United States | 97213 |
77 | Legacy Emanuel Hospital and Health Center | Portland | Oregon | United States | 97227 |
78 | St. Christopher's Hospital for Children | Philadelphia | Pennsylvania | United States | 19134-1095 |
79 | Medical University of South Carolina | Charleston | South Carolina | United States | 29425-0721 |
80 | Children's Hospital of Greenville Hospital System | Greenville | South Carolina | United States | 29605 |
81 | James H. Quillen College of Medicine | Johnson City | Tennessee | United States | 37614-0622 |
82 | Saint Jude Children's Research Hospital | Memphis | Tennessee | United States | 38105-2794 |
83 | Driscoll Children's Hospital | Corpus Christi | Texas | United States | 78466 |
84 | Texas Oncology P.A. | Dallas | Texas | United States | 75230-2503 |
85 | Medical City Dallas Hospital | Dallas | Texas | United States | 75230 |
86 | Simmons Cancer Center - Dallas | Dallas | Texas | United States | 75235-9154 |
87 | Cook Children's Medical Center - Fort Worth | Fort Worth | Texas | United States | 76104 |
88 | University of Texas Medical Branch | Galveston | Texas | United States | 77555-0209 |
89 | Baylor College of Medicine | Houston | Texas | United States | 77030 |
90 | San Antonio Military Pediatric Cancer and Blood Disorders Center | Lackland Air Force Base | Texas | United States | 78236-5300 |
91 | MBCCOP - South Texas Pediatric | San Antonio | Texas | United States | 78229-3900 |
92 | University of Texas Health Science Center at San Antonio | San Antonio | Texas | United States | 78284-7811 |
93 | Scott and White Clinic | Temple | Texas | United States | 76508 |
94 | Vermont Cancer Center | Burlington | Vermont | United States | 05401-3498 |
95 | Cancer Center at the University of Virginia | Charlottesville | Virginia | United States | 22908 |
96 | Inova Fairfax Hospital | Falls Church | Virginia | United States | 22042-3300 |
97 | Naval Medical Center, Portsmouth | Portsmouth | Virginia | United States | 23708-2197 |
98 | Massey Cancer Center | Richmond | Virginia | United States | 23298-0037 |
99 | Carilion Roanoke Community Hospital | Roanoke | Virginia | United States | 24029 |
100 | Madigan Army Medical Center | Tacoma | Washington | United States | 98431-5000 |
101 | West Virginia University Medical School-Charleston | Charleston | West Virginia | United States | 25304 |
102 | West Virginia University Hospitals | Morgantown | West Virginia | United States | 26506-9300 |
103 | St. Vincent Hospital | Green Bay | Wisconsin | United States | 54307-3508 |
104 | Midwest Children's Cancer Center | Milwaukee | Wisconsin | United States | 53226 |
105 | Royal Children's Hospital | Parkville | Victoria | Australia | 3052 |
106 | Alberta Children's Hospital | Calgary | Alberta | Canada | T2T 5C7 |
107 | Cross Cancer Institute | Edmonton | Alberta | Canada | T6G 1Z2 |
108 | Children's Hospital | Hamilton | Ontario | Canada | L8N 3Z5 |
109 | Children's Hospital of Eastern Ontario | Ottawa | Ontario | Canada | K1H 8L1 |
110 | Hospital for Sick Children | Toronto | Ontario | Canada | M5G 1X8 |
111 | McGill University Health Center - Montreal Children's Hospital | Montreal | Quebec | Canada | H3H 1P3 |
112 | Hopital Sainte Justine | Montreal | Quebec | Canada | H3T 1C5 |
113 | Centre Hospitalier de L'Universite Laval | Sainte Foy | Quebec | Canada | GIV 4G2 |
114 | Laval University Medical Center | Sainte-Foy | Quebec | Canada | G1V 4G2 |
115 | Academisch Ziekenhuis Groningen | Groningen | Netherlands | 9713 EZ | |
116 | San Jorge Childrens Hospital | Santurce | Puerto Rico | 00912 | |
117 | Swiss Pediatric Oncology Group Bern | Bern | Switzerland | CH 3010 | |
118 | Clinique de Pediatrie | Geneva | Switzerland | 1211 | |
119 | Centre Hospitalier Universitaire Vaudois | Lausanne | Switzerland | CH-1011 |
Sponsors and Collaborators
- Children's Oncology Group
- National Cancer Institute (NCI)
Investigators
- Study Chair: Kimo C. Stine, MD, Arkansas Children's Hospital at the University of Arkansas for Medical Sciences
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- 9674
- POG-9674
- CDR0000065574